abstract |
The present invention relates to modified Factor IX coding sequences, expression cassettes, vectors such as viral (eg, lenti- or adeno-associated virus) vectors, and methods and uses of gene delivery. In particular, it relates to targeting factor IX nucleic acids into cells, tissues or organs for expression (transcription) of factor IX. |